Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Enanta Pharmaceuticals Inc (ENTA)
Enanta Pharmaceuticals Inc (ENTA) Financials

ENTA Enanta Pharmaceuticals Inc

5.58

-0.01 (-0.18%)

Last Updated: 20:41:16

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 30 September 2024	2017	2018	2019	2020	2021	2022	2023	2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	5.826	19.425	10.261	-7.412	-17.082	-29.908	-31.949	-27.665
Return on Equity (%)	6.197	20.696	10.835	-7.879	-18.478	-33.785	-49.739	-67.166
Return on Invested Capital (%)	6.801	22.771	9.962	-10.598	-22.745	-42.725	-56.084	-71.117
Operating Margin (%)	26.248	45.068	22.202	-28.593	-110.822	-141.815	-158.89	-157.977
Net Profit Margin (%)	17.225	34.824	22.604	-29.531	-81.377	-141.313	-168.951	-171.575
Book Value Per Share	15.778	20.298	23.473	22.692	19.737	15.508	10.294	6.08
Earnings Per Share	0.926	3.71	2.354	-1.801	-3.903	-5.876	-6.356	-5.477
Cash Per Share	3.435	3.295	2.6	4.34	2.827	2.123	4.055	1.757
Working Capital Per Share	11.341	18.786	19.248	20.555	13.976	13.605	17.098	11.437
Operating Profit Per Share	5.377	10.654	10.415	6.1	4.797	4.158	3.762	3.192
EBIT Per Share	1.409	4.801	2.312	-1.744	-5.316	-5.897	-6.222	-5.559
EBITDA Per Share	1.409	4.801	2.312	-1.744	-5.316	-5.897	-6.222	-5.559
Free Cash Flow Per Share	0.946	3.734	2.464	-1.911	-4.031	-5.917	-6.038	-4.74

Liquidity Ratios

Year End 30 September 2024	2017	2018	2019	2020	2021	2022	2023	2024
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	19.12M	19.4M	19.7M	20.08M	20.24M	N/A	N/A	N/A

Key Stats and Ratios

Year End 30 September 2024	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	20.88M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	-123.044	N/A	N/A	N/A	-169.905	N/A	N/A	N/A
Net Profit Margin (%)	-122.9	N/A	N/A	N/A	-185.564	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	118.48M
Price to Earnings Ratio	-1
Price to Sales Ratio	1.72
Price to Cash Ratio	3.13
Price to Book Ratio	0.9
Dividend Yield	-

Share Statistics

Shares Outstanding	21.19M
Average Volume (1 week)	1.33M
Average Volume (1 Month)	736.51k
52 Week Change	-44.09%
52 Week High	17.80
52 Week Low	5.30

More Ratios Coming Soon!

Enanta Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions